Pain Assessment and
Intervention
|
|||
Signs and Symptoms by Developmental Stage
|
|||
■ Infant: Grimacing, frowning, startled expression, flinching,
high-pitched, harsh cry, generalized, total-body response, extremities may
thrash about, tremors, increased HR and BP, ↓ oxygen
saturation.
■ Toddler: Guarding, may touch or rub area, generalized
restlessness, loud cry, increased HR and BP, may verbalize with words such as
“owie” or “boo-boo.”
■ Preschooler: May perceive pain as punishment, may deny pain to avoid treatment,
may be able to describe location and intensity, may exhibit crying and
kicking, or may be withdrawn.
■ School-aged: Fear of bodily harm and mutilation, awareness of death, able
to describe pain, may exhibit stiff body posture, may withdraw, and may
attempt to delay procedures.
■ Adolescent: Perceives pain at physical, emotional, and mental
levels, is able to describe pain, may exhibit increased muscle tension, may
be
withdrawn,
and may show decreased motor activity.
|
|||
Interventions for Pain
|
|||
Nonopioid Analgesics
■ Acetaminophen (Tylenol): 10–15 mg/kg PO q.4h., max five doses/day.
■ Ibuprofen (Advil): (>2 yr) 7.5 mg/kg PO q.i.d., max 30 mg/kg/day.
■ Naproxen (Naprosyn): (>2 yr) 5 mg/kg PO b.i.d., max two doses.
Opioid Analgesics
■ Codeine: (>1
yr) 0.5 mg/kg (15 mg/m2) PO, IM, SC q.4–6h., max four doses/day. Note: Not
recommended for IV use. Infants may receive SC or IM codeine at same dose.
■ Meperidine (Demerol): 1.1–1.8 mg/kg PO, IM, SC q.3–4h. p.r.n., max 50–100
mg/dose.
■ Morphine: 0.1–0.2
mg/kg IV, IM, or SC p.r.n., max 15 mg/dose.
■ Sublimaze (Fentanyl): (>2 yrs) 2–3 ug/kg IV.
Nonpharmacologic Interventions
■ Distraction: Music, TV, games, dolls, stuffed animals, art, etc.
■ Minimize environmental stimuli: Noises, bright lights, etc.
■ Provide comfort: Positioning, rest, and relaxation
■ Cutaneous stimulation: Massage or heat or cold therapy.
■ Guided imagery: Guide the child to either a make-believe place or someplace he
or she has visited in the past (i.e., Disneyland). Encourage
the child to describe this place.
|
|||
Pediatric
IM Injection Sites
|
|||
|
Muscle*
|
Needle
|
Max Volume
|
Infant
|
Ventrogluteal or vastus lateralis
|
5/8–7/8”
|
1 mL
|
Toddler
|
Ventrogluteal or vastus lateralis
|
5/8–1”
|
1 mL
|
Older child
|
Ventrogluteal or deltoid
|
5/8–1”
|
1 mL
|
*The dorsogluteal site is contraindicated in
infants and children.
|
7/15/14
Pain Assessment and Intervention
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment